April 11, 2011: Algos Preclinical Services, Inc. (Algos) is pleased to announce that Cara Wykowski has joined as Director, Business Development. Cara was formerly with The Jackson Laboratory specializing in complete colony management and preclinical efficacy studies in the areas of metabolics, oncology and autoimmune diseases. Cara has over 18 years of sales and business development experience in the life sciences industry. “We are excited that Cara has joined us and it has allowed us to double our business development efforts and increase our focus on proactive customer service”, said Ganesh Iyer, President and CEO of Algos.
Based in the San Francisco Bay area, Cara started with Algos last month and will be responsible for developing and expanding business in the Western US/ Canada, South America, Asia and Australia. Mr. Frank Eichmann will continue to be responsible for business development and growth in the Eastern US/Canada, Europe, Middle-East and Africa.
Algos is a premier contract research organization focusing on preclinical pain in vivo services and providing critical support to its clients in the pharma/biotech and medical device industries. Algos delivers the timely and definitive results that its clients count on to maintain their first to market advantage. This has allowed Algos to help its clients to make uninterrupted progress on their development candidates, despite the tumultuous times in the pharma/biotech sector in general in recent years. Algos is experiencing an increase in demand for its services and is poised for continued growth.